HR 7 prohibits federal funds from being used for abortions or health insurance plans covering abortion, with exceptions for pregnancies resulting from rape, incest, or when a woman's life is endangered. It blocks federal premium tax credits under the Affordable Care Act for health plans covering abortion (except in specified cases) and requires clear disclosure of abortion coverage and related surcharges in plan materials. The bill allows individuals or employers to purchase separate abortion coverage using non-federal funds, such as out-of-pocket payments, without affecting federal subsidies. It directly affects federal health programs, ACA marketplace plans, and health insurance issuers offering coverage that includes abortion services.
Living Donor Protection Act of 2025 This bill prohibits life insurance, disability insurance, and long-term insurance carriers from denying or otherwise restricting coverage for living organ donors. Specifically, carriers may not deny, cancel, vary premiums, or otherwise impose conditions on policies based on an individual's status as a living organ donor. The bill also expressly specifies that recovery from organ-donation surgery constitutes a serious health condition that entitles eligible employees to job-protected medical leave. In addition, the Department of Health and Human Services must update educational materials on living organ donation to include information about the benefits and risks of living organ donation and the impact of donation on insurance access, particularly with respect to the bill's changes.
Further Additional Continuing Appropriations and Other Extensions Act, 2025 This bill provides continuing FY2025 appropriations for federal agencies through April 11, 2025. It also extends various expiring programs and authorities, including several public health programs. Specifically, the bill provides continuing FY2025 appropriations to federal agencies through the earlier of April 11, 2025, or the enactment of the applicable appropriations act. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2025 appropriations bills have not been enacted when the existing CR expires on March 14, 2025. The CR funds most programs and activities at the FY2024 levels with some exceptions that provide funding flexibility and additional appropriations for various programs. For example, the CR provides additional emergency funding for the Federal Emergency Management Agency's Disaster Relief Fund, permits the Navy to apportion funds at the rate necessary to fund the Columbia-class submarine program and cost increases for certain shipbuilding programs, and provides additional funding for the Office of Navajo and Hopi Relocation. In addition, the bill extends several expiring programs and authorities, including several public health, Medicare, and Medicaid authorities and programs; authorities related to the Commodity Futures Trading Commission whistleblower program; authorities for the Department of Homeland Security and the Department of Justice to take actions to mitigate a credible threat from an unmanned aircraft system; the special assessment on nonindigent persons or entities convicted of certain offenses involving sexual abuse or human trafficking; and the National Cybersecurity Protection System.
This bill expands VA transportation grants to help rural veterans access medical care by modifying existing grant program rules. It adds "rural or highly rural" eligibility criteria, allows grants to fund vehicles meeting ADA requirements (up to $80,000), and explicitly includes county veterans service organizations and tribal organizations as eligible recipients. The bill defines "rural" using USDA's RUCA coding system and removes fixed funding caps, directing the VA to provide "such sums as may be necessary" for these grants. It directly affects rural veterans needing transportation to medical appointments and the local organizations that coordinate their care.
Precision Brain Health Research Act of 2025 This bill expands the Scott Hannon Initiative for Precision Mental Health, a program at the Department of Veterans Affairs (VA). Specifically, the bill expands the scope of the initiative by requiring the identification and validation of brain and mental health biomarkers among veterans for repetitive low-level blast exposure, dementia, and other such brain conditions. Currently, the initiative addresses several other conditions such as depression and post-traumatic stress disorder. The VA must work with the Department of Defense to establish a data-sharing partnership under the initiative. The bill requires the VA to conduct various research studies about repetitive low-level blast exposure under the initiative. The VA must seek to enter into a contract with the National Academies of Sciences, Engineering, and Medicine to work in tandem with the initiative on validation of brain and mental health biomarkers among veterans and report on the findings at least once every two years. The VA must assess all in progress and planned translational research studies under the initiative and report to Congress on the assessment. Additionally, the VA must report to Congress on the initiative at least once every two years and include recommendations for immediate administrative and legislative action to improve the initiative. The bill authorizes the initiative through FY2034.
HR 6863, the CAT Act of 2025, requires the Centers for Medicare & Medicaid Services (CMS) to provide Medicare and Medicaid providers with greater transparency and due process when payments are suspended due to fraud allegations. The bill limits payment suspensions to 180 days unless "good cause" is shown, mandates CMS to explain the specific fraud allegations and evidence to providers within 30 days, and requires regular updates during suspensions. It also establishes a new appeals process for providers to challenge suspensions within 180 days of the law's enactment and requires annual reports to Congress on suspension statistics. This directly affects healthcare providers whose payments are suspended, aiming to prevent unnecessary financial harm to those acting in good faith.
This bill updates federal grant programs to expand access to long-acting injectable medications, lab testing, and counseling for people with substance use disorders or serious mental illness. It requires grant recipients (state/local health agencies) to provide these specific services and train clinicians on medication use. The changes apply to new grants starting after the bill's enactment. Annual reports on program outcomes must also be submitted to Congress.
HR 1878 creates a new federal tax credit for out-of-pocket expenses related to fertility treatments like IVF. It allows eligible taxpayers to claim a credit equal to up to $20,000 per year (or $40,000 for joint filers) for qualifying expenses, subject to income limits ($200,000 AGI for individuals, $400,000 for couples). The credit phases out for taxpayers earning above these thresholds and cannot be claimed for expenses covered by insurance or other deductions. This directly affects individuals and couples seeking fertility treatments who pay for them out-of-pocket.
HR 2426 requires the VA Secretary to commission an independent study comparing the quality of mental health and addiction care provided by VA health care providers versus non-VA providers for veterans. The study must examine health outcomes, use of proven treatment methods, care coordination, veteran satisfaction, and access times across different care types like telehealth and in-person visits. It mandates a report to Congress and public release within 18 months, detailing findings on factors like symptom improvement, suicide risk assessment, and whether veterans with multiple conditions receive integrated care. This bill directly affects veterans seeking mental health or addiction therapy services and aims to identify gaps in care quality between VA and non-VA systems.
This bill, S 2770 (Share the Savings with Seniors Act), changes Medicare Part D drug coverage for seniors taking specific chronic medications. It requires that for covered chronic care drugs (like blood glucose regulators, anticoagulants, and certain inhalers), beneficiaries pay no more than the drug’s actual negotiated price (net price) for costs below the deductible, and coinsurance above the deductible must be based on that net price. The rules apply to plan years starting January 1, 2027, directly affecting Medicare Part D enrollees using drugs in the defined categories. The bill clarifies that cost-sharing for these drugs cannot exceed the negotiated price, aiming to reduce out-of-pocket costs for seniors on long-term medications.
